Senior insider sale
Chief Development Officer at LEXEO THERAPEUTICS, INC. — senior position signals high conviction
$28.3K
4.25K shares
What this filing means
SEE TAI SANDI plans to sell 4.25K shares of LEXEO THERAPEUTICS, INC. valued at approximately $28.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/18/2026ACC: 0001959173-26-001143
Officer· Chief Development Officer
Since Feb 2024
4.25K
Shares to sell
$28.3K
Approx. market value
3.86K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/17/2026
3.86KTotal acquired3.86K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/17/2026 | Restricted Stock Vesting Compensation | 3.86K | — |
| Total | 3.86K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
386.00
Market value
$3.6K
11/18/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.86K
Market value
$24.7K
2/18/2026
Total
Units
4.25K
Value
$28.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/18/2025 | 386.00 | $3.6K | — | Completed |
| Planned — Approximate Date | ||||
2/18/2026 | 3.86K | $24.7K | NASDAQ | Planned |
| Total | 4.25K | $28.3K | ||